Intracerebral hemorrhage due to hemorrhagic disease of the newborn and failure to administer vitamin K at birth

Southern Medical Journal

Volumn 99, Issue 11, 2006, Pages 1216-1220

  Hubbard, Dena ^a   Tobias, Joseph D ^a,b,c,d  

^a UNIVERSITY OF MISSOURI   (United States)

^b Department of Anesthesiology ^*  (United States)

^c Division of Pediatric Anesthesiology   (United States)

^d University of Missouri   (United States)

Author keywords

Hemorrhagic disease of the newborn; Intracerebral hemorrhage; Recombinant factor VIIa; Vitamin K

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

ANASTOMOSIS; ARTICLE; BLOOD CLOTTING; BRAIN HEMORRHAGE; CASE REPORT; CHILDBIRTH; CLINICAL FEATURE; CRANIOTOMY; DELIVERY; DISEASE SEVERITY; HEMATOMA; HUMAN; INFANT; INTRACRANIAL PRESSURE; MALE; NEUROLOGIC DISEASE; NEWBORN HEMORRHAGIC DISEASE; PROPHYLAXIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; CEREBRAL HEMORRHAGE; FACTOR VII; FATAL OUTCOME; HEMORRHAGIC DISEASE OF NEWBORN; HUMANS; INFANT; INFANT, NEWBORN; MALE; RECOMBINANT PROTEINS; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN K;

EID: 33845314710     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000233215.43967.69     Document Type: Article

References (25)

1. Qureshi AI, Tuhrim S, Borderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450-1460.
2. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003;34:224-229.
3. Chen ST, Chen SD, Hsu CY, et al. Progression of hypertensive intracerebral hemorrhage. Neurology 1989;39:1509-1514.
4. Sutherland JM, Glueck HI, Gleser G. Hemorrhagic disease of the newborn: breast feeding as a necessary factor in pathogenesis. Am J Dis Child 1967;113:524-533.
5. Aballi AJ, de Lamercus S. Coagulation changes in the neonatal period and in early infancy. Pediatr Clin North Am 1962;9:785-812.
6. Haroon Y, Shearer MJ, Rahim S, et al. The content of phylloquinone (vitamin K1) in human milk, cow's milk and infant formula foods determined by high-performance liquid chromatography. J Nutr 1982;112:1105-1117.
7. Townsend CW. The haemorrhagic disease of the newborn. Arch Paediatr 1894;11:559-562.
8. Dam CPH. Cholesterinstoffwechsel in Huhnereierin und Huhnchen. Biochem Zeitschr 1929;215:475-478.
9. Waddell WW, Guerry D. The role of vitamin K in the etiology, prevention, and treatment of hemorrhage in the newborn infant: part II J Pediatr 1939;15:802-811.
10. American Academy of Pediatrics, Committee on Nutrition. Vitamin K compounds and the water-soluble analogues: use in therapy and prophylaxis in pediatrics. Pediatrics 1961;28:501-507.
11. Kugelmass IN. The management of hemorrhagic problems in infant and childhood. JAMA 1932;99:895-897.
12. Clifford SH. Hemorrhagic disease of the newborn: a critical consideration. J Pediatr 1941;18:333-335.
13. Lucey JF, Dolan RG. Hyperbilirubinemia of newborn infants associated with the parenteral administration of a vitamin K analogue to the mothers. Pediatrics 1959;23:553-560.
14. Golding J, Paterson M, Kinlen LJ. Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990;62:304-308.
15. Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992;305:341-346.
16. Ross JA, Davies SM. Vitamin K prophylaxis and childhood cancer. Med Pediatr Oncol 2000;34:434-437.
17. Draper GJ, Stiller CA. Intramuscular vitamin K and childhood cancer. BMJ 1992;305:709-711.
18. American Academy of Pediatrics, Vitamin K Ad Hoc Task Force. Controversies concerning vitamin K and the newborn (revised). Pediatrics 2003;112:191-192.
19. Cornelissen EA, Kollee LA, De Abreau RA, et al. Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child 1992;67:1250-1254.
20. Cornelissen M, Von Kries R, Loughnan P, et al. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 1997;156:126-130.
21. Greer FR, Marshall SP, Severson RR, et al. A new mixed micellar preparation for oral vitamin K prophylaxis: randomized controlled comparison with an intramuscular formulation in breastfed infants. Arch Dis Child 1998;79:300-305.
22. Cote CJ, Drop LJ, Hoaglin DC, et al. Ionized hypocalcemia after fresh frozen plasma administration to thermally injured children: effects of infusion rate, duration, and treatment with calcium chloride. Anesth Analg 1988;67:152-160.
23. Tobias JD, Groeper K, Berkenbosch JW. Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 2003;96:12-16.
24. Tobias JD. Recombinant factor VIIa in pediatric patients. TATM 2003;5:40-44.
25. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.